Home › Geographic Atrophy › Texas › The Woodlands
Geographic Atrophy clinical trials in The Woodlands, TX
6 studies for Geographic Atrophy are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Retina Consultants of Texas, The Woodlands
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
RecruitingPhase 2
- Retina Consultants of Texas, The Woodlands
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Retina Consultants Texas, The Woodlands
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Retina Consultants of Texas, The Woodlands
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
RecruitingPhase 1
- Retina Consultants Texas, The Woodlands
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Retina Consultants - The Woodlands /ID# 262138, The Woodlands
Geographic Atrophy trials in other cities
- Reno, NV8 studies
- Dallas, TX8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Cleveland, OH6 studies
- Naperville, IL6 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- St. Louis, MO5 studies
- Washington, DC5 studies
- Erie, PA5 studies
- Spokane, WA5 studies
Other studies in The Woodlands
- Non-Small Cell Lung Cancer15 studies
- Obesity12 studies
- Overweight10 studies
- Breast Cancer10 studies
- Macular Degeneration9 studies
- Cardiovascular Disease9 studies
- Metastatic Cancer9 studies
- Type 2 Diabetes7 studies
- Heart Failure7 studies
- Lung Cancer7 studies
- Atherosclerosis6 studies
- Prostate Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.